Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Only 200 shares traded @ 10:15
View:
Post by GoldenInvestor on Sep 09, 2022 10:16am

Only 200 shares traded @ 10:15

Is there a halt?  News pending?

just curious.
Comment by MrMugsy on Sep 10, 2022 2:25pm
Actually Golden ... if you look at the top of this Stockhouse siite - to the right of the GUD share price, you will see the bid/ask identified.  If one of those is replaced by a red circle with a number 2 in it (don't quote me on the actual way it looks) ... you will see if there is a hold on the company. Actually - if you go to C.BEAN you can see a company that is halted.  A red ...more  
Comment by GoldenInvestor on Sep 10, 2022 4:30pm
Thanks!  I figured it wasn't but was curious why nothing had traded , just 200 shares u til >+45 mins in. it seemed stranger then picked up thereafter 
Comment by MrMugsy on Sep 11, 2022 10:04am
I missed that - was on a train going to the Antibe AGM. Just love the potential at ATE for GUD shareholders - got my fingers crossed for a future of opportunity there.  Wouldn't surprise me if GUD's shelf prospectus is earmarked for the 346 asset in LATAM.  Maybe - maybe not.  Time will tell. BTW ... Phase 2 346 in acute pain starts in late September (3rd Molar Extraction) ...more